Device comprising a cation ion-exchanger for reducing the acidity of motor oil and engine with such device
US-9212577-B2 · Dec 15, 2015 · US
US9238221B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9238221-B2 |
| Application number | US-201514603477-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 23, 2015 |
| Priority date | Dec 16, 2009 |
| Publication date | Jan 19, 2016 |
| Grant date | Jan 19, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A curable composition comprising: (i) 2.5 to 50 wt % crosslinker comprising at least two acrylamide groups; (ii) 20 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and an anionic group; (iii) 15 to 45 wt % solvent; and (iv) 0 to 10 wt % of free radical initiator; wherein the molar ratio of (i):(ii) is 0.1 to 1.5. The compositions are useful for preparing ion exchange membranes.
Opening claim text (preview).
The invention claimed is: 1. A membrane obtained by a process comprising the following steps: applying a curable composition to a support; and curing the composition to form a membrane; wherein the curable composition comprises: (i) 7.47 to 43.33 wt % crosslinker comprising at least two acrylamide groups; (ii) 20 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and an anionic group; (iii) 15 to 45 wt % solvent; and (iv) 0 to 10 wt % of free radical initiator; wherein the molar ratio of (i):(ii) is from 0.1 to 1.5. 2. The membrane according to claim 1 wherein (a) the molar ratio of (i):(ii) is from 0.1 to 1.0; (b) the ethylenically unsaturated group is an acrylamide group or a methacrylamide group; and (c) the composition contains 20 to 40 wt % solvent. 3. The membrane according to claim 1 wherein (a) the composition comprises 20 to 40 wt % solvent; (b) the total wt % of components (i) and (ii) relative to the total weight of the composition is 30 to 85 wt %; (c) the solvent comprises at least 40 wt % water; and (d) the molar ratio of (i):(ii) is from 0.13 to 0.7. 4. The membrane according to claim 1 wherein the total wt % of components (i) and (ii) relative to the total weight of the composition is 30 to 85 wt %. 5. The membrane according to claim 1 wherein the solvent comprises at least 40 wt % water. 6. The membrane according to claim 1 wherein the composition comprises 0.005 to 10 wt % photoinitiator. 7. The membrane according to claim 1 wherein the composition is free from ethylenically unsaturated compounds other than components (i) and (ii). 8. The membrane according to claim 1 wherein the curable composition comprises: (i) 8 to 16 wt % crosslinker comprising at least two acrylamide groups; (ii) 40 to 60 wt % curable ionic compound comprising an ethylenically unsaturated group and an anionic group; (iii) 22 to 40 wt % solvent; and (iv) 0.01 to 2 wt % of photoinitiator; wherein the molar ratio of (i):(ii) is from 0.1 to 1.0. 9. The membrane according to claim 1 wherein the curing is performed using electron beam or UV radiation. 10. The membrane according to claim 1 wherein the composition is cured by irradiation with an electron beam or UV light for a period of less than 30 seconds. 11. The membrane according to claim 1 wherein the curable composition is applied continuously to a moving support using a manufacturing unit comprising a curable composition application station, an irradiation source for curing the composition, and a membrane collecting station and wherein the support moves from the curable composition application station to the irradiation source and to the membrane collecting station. 12. The membrane according to claim 8 wherein the curing is performed using electron beam or UV radiation. 13. The membrane according to claim 8 wherein the composition is cured by irradiation with an electron beam or UV light for a period of less than 30 seconds.
Capacitive deionisation · CPC title
containing oxygen in addition to the carbonamido oxygen {, e.g. N-methylolacrylamide, N-(meth)acryloylmorpholine} · CPC title
by ion-exchange (ion-exchange in general B01J) · CPC title
Dialytic cells or batteries; Reverse electrodialysis cells or batteries · CPC title
Electrolytic cell with membranes or diaphragms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.